Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(Q1)2025/03/31 | (FY)2024/12/31 | (Q4)2024/12/31 | (Q3)2024/09/30 | (Q2)2024/06/30 | (Q1)2024/03/31 | (FY)2023/12/31 | (Q4)2023/12/31 | (Q3)2023/09/30 | (Q2)2023/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
营业总收入 | 13.53%4,563.5万 | 15.92%1.7亿 | 17.20%4,612.2万 | 15.76%4,267.3万 | 15.00%4,148.4万 | 15.62%4,019.6万 | 19.86%1.47亿 | 15.37%3,935.4万 | 9.68%3,686.2万 | 27.15%3,607.4万 |
净利息收入 | 12.39%4,279.7万 | 15.22%1.61亿 | 16.36%4,343.8万 | 14.50%4,038.3万 | 13.97%3,885.8万 | 15.99%3,807.9万 | 19.81%1.4亿 | 16.11%3,733.1万 | 12.48%3,526.8万 | 22.92%3,409.6万 |
-利息收入总计 | 2.40%8,076.6万 | 23.19%3.28亿 | 10.99%8,553.6万 | 19.22%8,271.9万 | 29.52%8,122.5万 | 37.46%7,887.6万 | 73.14%2.67亿 | 50.67%7,706.7万 | 60.98%6,938.5万 | 92.91%6,271.3万 |
-其中:贷款利息收入 | 3.42%7,308.7万 | 18.62%2.95亿 | 8.09%7,601.7万 | 15.43%7,546.8万 | 23.29%7,310.3万 | 31.09%7,067.1万 | 69.99%2.49亿 | 46.26%7,032.5万 | 61.44%6,538万 | 90.27%5,929.5万 |
-其中:证券利息收入 | 84.06%569.3万 | 105.16%1,705.5万 | 79.86%493.9万 | 127.74%453.2万 | 121.34%449.1万 | 99.81%309.3万 | 111.80%831.3万 | 97.84%274.6万 | 45.57%199万 | 126.96%202.9万 |
-利息费用总计 | -6.93%3,796.9万 | 31.95%1.68亿 | 5.94%4,209.8万 | 24.09%4,233.6万 | 48.05%4,236.7万 | 66.19%4,079.7万 | 238.79%1.27亿 | 109.14%3,973.6万 | 190.43%3,411.7万 | 499.81%2,861.7万 |
-其中:存款利息支出 | -6.39%3,622.6万 | 38.86%1.6亿 | 6.80%4,023.3万 | 33.16%4,040.7万 | 62.05%4,041万 | 75.17%3,869.8万 | 274.78%1.15亿 | 140.22%3,767.1万 | 211.97%3,034.5万 | 624.25%2,493.6万 |
-其中:长期贷款及资本证券利息支出 | -16.96%174.3万 | -34.45%785万 | -9.69%186.5万 | -48.86%192.9万 | -46.84%195.7万 | -14.57%209.9万 | 76.21%1,197.5万 | -37.76%206.5万 | 86.73%377.2万 | 177.18%368.1万 |
非利息收入总计 | 34.06%283.8万 | 29.01%971.7万 | 32.67%268.4万 | 43.66%229万 | 32.76%262.6万 | 9.29%211.7万 | 20.80%753.2万 | 3.27%202.3万 | -29.28%159.4万 | 211.99%197.8万 |
-已赚总保险费总额 | 16.32%67.7万 | 18.04%248万 | 18.43%66.2万 | 19.96%64.9万 | 11.60%58.7万 | 22.53%58.2万 | 60.14%210.1万 | 12.47%55.9万 | 27.59%54.1万 | 112.10%52.6万 |
-佣金收入 | 57.00%200.8万 | 135.59%603.1万 | 121.09%158.3万 | 213.07%191.6万 | 199.76%125.3万 | 57.13%127.9万 | 48.32%256万 | 27.40%71.6万 | 25.41%61.2万 | 24.78%41.8万 |
-其他非利息收入 | 11,600.00%35.1万 | -39.46%118万 | -45.66%43.8万 | 153.06%10.4万 | -19.31%63.5万 | -99.46%3,000 | -13.26%194.9万 | -48.63%80.6万 | -165.33%-19.6万 | 337.22%78.7万 |
-资产出售收益 | -178.26%-19.8万 | -97.18%2.6万 | 101.72%1,000 | -159.50%-37.9万 | -38.87%15.1万 | 163.54%25.3万 | -2.95%92.2万 | 91.33%-5.8万 | -38.87%63.7万 | 291.47%24.7万 |
信贷损失准备金 | 71.15%-45万 | 9.79%-570.1万 | -5.09%-115.6万 | 58.59%-108.5万 | -35.71%-190万 | -30.00%-156万 | 48.20%-632万 | 43.59%-110万 | 9.66%-262万 | 58.21%-140万 |
非利息费用 | 8.37%2,783.9万 | 4.34%1.03亿 | 2.90%2,704.1万 | -7.00%2,532.7万 | 7.79%2,536.7万 | 16.35%2,568.8万 | 13.52%9,912.5万 | 15.10%2,628万 | 21.34%2,723.3万 | 6.29%2,353.3万 |
设备占用费 | 5.98%409.3万 | 16.96%1,597.7万 | 9.26%405.8万 | 11.74%408.3万 | 20.17%397.4万 | 29.38%386.2万 | 43.22%1,366万 | 28.69%371.4万 | 43.29%365.4万 | 62.83%330.7万 |
专业费用和合同服务费用 | 3.32%143.1万 | -27.66%563万 | -31.15%158.7万 | -48.18%103.7万 | 4.78%162.1万 | -28.24%138.5万 | 11.39%778.3万 | 22.15%230.5万 | 47.89%200.1万 | -22.69%154.7万 |
销售和管理费用 | 11.23%1,875万 | 3.05%6,682.3万 | 4.85%1,754.4万 | -9.90%1,609.9万 | 3.02%1,632.3万 | 17.08%1,685.7万 | 10.99%6,484.4万 | 11.16%1,673.3万 | 17.89%1,786.8万 | 9.57%1,584.5万 |
-管理费用 | 11.14%1,834.1万 | 4.66%6,511.6万 | 5.58%1,701.8万 | -9.65%1,567.9万 | 5.88%1,591.7万 | 20.35%1,650.2万 | 10.10%6,221.7万 | 11.37%1,611.9万 | 17.90%1,735.3万 | 7.42%1,503.3万 |
-销售费用 | 15.21%40.9万 | -35.02%170.7万 | -14.33%52.6万 | -18.45%42万 | -50.00%40.6万 | -48.25%35.5万 | 37.40%262.7万 | 5.86%61.4万 | 17.58%51.5万 | 73.88%81.2万 |
其他非利息费用 | -0.53%356.5万 | 16.79%1,499.3万 | 9.18%385.2万 | 10.73%410.8万 | 21.70%344.9万 | 29.57%358.4万 | 3.75%1,283.8万 | 17.33%352.8万 | 9.63%371万 | -22.31%283.4万 |
来自联营公司及其他参与权益的收入(亏损) | ||||||||||
特殊收入(费用) | ||||||||||
其他非经营收入(费用) | ||||||||||
除税前利润 | 33.97%1,734.6万 | 47.44%6,135.1万 | 49.70%1,792.5万 | 132.00%1,626.1万 | 27.61%1,421.7万 | 12.71%1,294.8万 | 79.61%4,161.2万 | 28.38%1,197.4万 | -15.20%700.9万 | 286.71%1,114.1万 |
所得税 | 45.56%375.7万 | 66.61%1,368万 | 83.46%419.2万 | 143.61%348.6万 | 52.04%342.1万 | 14.97%258.1万 | 82.10%821.1万 | 26.80%228.5万 | -4.28%143.1万 | 272.52%225万 |
除税后的权益收益 | ||||||||||
除税后利润 | 31.08%1,358.9万 | 42.72%4,767.1万 | 41.74%1,373.3万 | 129.02%1,277.5万 | 21.43%1,079.6万 | 12.16%1,036.7万 | 79.01%3,340.1万 | 28.76%968.9万 | -17.61%557.8万 | 290.47%889.1万 |
持续经营利润 | 31.08%1,358.9万 | 42.72%4,767.1万 | 41.74%1,373.3万 | 129.02%1,277.5万 | 21.43%1,079.6万 | 12.16%1,036.7万 | 79.01%3,340.1万 | 28.76%968.9万 | -17.61%557.8万 | 290.47%889.1万 |
归属于少数股东的净利润 | ||||||||||
归属于母公司的净利润 | 31.08%1,358.9万 | 42.72%4,767.1万 | 41.74%1,373.3万 | 129.02%1,277.5万 | 21.43%1,079.6万 | 12.16%1,036.7万 | 79.01%3,340.1万 | 28.76%968.9万 | -17.61%557.8万 | 290.47%889.1万 |
优先股派息 | 0.00%117.1万 | 0.27%474.9万 | -0.08%119.6万 | 1.18%119.8万 | 0.00%118.4万 | 0.00%117.1万 | 233.99%473.6万 | 119.7万 | 118.4万 | 118.4万 |
其他优先股派息 | ||||||||||
归属于普通股股东的净利润 | 35.04%1,241.8万 | 49.74%4,292.2万 | 47.63%1,253.7万 | 163.47%1,157.7万 | 24.72%961.2万 | 13.92%919.6万 | 66.26%2,866.5万 | 39.05%849.2万 | -35.10%439.4万 | 238.47%770.7万 |
基本每股收益 | 32.35%0.9 | 48.82%3.14 | 48.39%0.92 | 165.63%0.85 | 22.81%0.7 | 13.33%0.68 | 64.84%2.11 | 37.78%0.62 | -36.00%0.32 | 235.29%0.57 |
稀释每股收益 | 27.87%0.78 | 40.40%2.78 | 38.60%0.79 | 131.25%0.74 | 18.87%0.63 | 10.91%0.61 | 58.40%1.98 | 29.55%0.57 | -34.69%0.32 | 231.25%0.53 |
每股派息 | ||||||||||
货币单位 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
会计准则 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
审计意见 | -- | 无保留意见 | -- | -- | -- | -- | 无保留意见 | -- | -- | -- |